At a time when cancer is spreading at a disturbingly fast pace across the globe, an Israeli biotech company has claimed that they will have the cure for this deadly disease by 2020.
Although different types of treatments are available in the market, but nothing promises to cure this deadly disease 100percent. But Accelerated Evolution Biotechnologies Ltd (AEBi), founded in 2000 from the ITEK Weizmann technology incubator has made bold claims to cure the disease completely, reports science journal The Live Science on Thursday.
Aridor, chairman of the board of AEBi, has asserted that their cancer cure will be effective from the very first day and will last for a few weeks. Additionally, their medicines will have “no or minimal side-effects”. He further said that the cure for cancer will be available at a much lower cost than other treatments available in the market.
The treatment which the biotech company calls MuTaTo (multi-target toxin) is based on SoAP technology, which belongs to the phage display group of technologies.
CEO of the biotech company Dr Ilan Morad said they started with identifying why other cancer-related drugs and treatment are not working and then they looked for an effective way to counter it.
Most cancer drugs attack a specific target or on the cancer cell, but MuTaTo attacks the cancer cell's receptors from three different directions.
“Instead of attacking receptors one at a time, we attack receptors three at a time. Not even cancer can mutate three receptors at one time," said Morad.
After a successful mice trail, Morad said that the company is now preparing to try medicines on humans through this year. Following this, they will introduce the medicine in the market by next year.
The claim made by the biotech company sounds very exciting when around 18. 1 million new cases of cancer are being diagnosed every year across the globe.